Results 211 to 220 of about 38,923 (293)
Regional Anaesthesia, Contemporary Techniques, and Associated Advancements: A Narrative Review. [PDF]
Gohad R, Jain S.
europepmc +1 more source
How Supply Networks Influence Sustainable Innovation: Evidence From Ghana's Public Works Procurement
ABSTRACT Recent environmental and sustainability standards in procurement increase short‐term production and operational costs to suppliers, which are often recouped by charging price premiums for innovative solutions. However, public buyers are less likely to pay such price premiums, resulting in a disincentive among suppliers to bid for innovation ...
Peter Adjei‐Bamfo +5 more
wiley +1 more source
EXPERIMENTAL STUDIES ON INTRAVENOUS REGIONAL ANAESTHESIA USING RADIOACTIVE LIGNOCAINE
Shamay Cotev, Gordon C. Robin
openalex +1 more source
ABSTRACT The aim of this study was to identify branches of the trigeminal and facial nerves (FNs) relevant to surgical incisions and injections and the scalp block techniques in the frontotemporal region, and to determine their relationships with superficial vascular structures and bony landmarks.
Hannah L. Grimes +5 more
wiley +1 more source
Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?
Pankaj Kundra, PSakthi Rajan
openalex +1 more source
Abstract Background Precise control of corticotomy lines is critical in surgically facilitated orthodontic therapy. The Suya method is traditionally performed freehand, which introduces risks of root damage and procedural inconsistency. A digitally guided protocol may address these limitations by enhancing safety and technical predictability. Methods A
Yosuke Tsukiboshi +3 more
wiley +1 more source
Intravenous regional anaesthesia for lower limb orthopaedic surgery.
Breanne Flood, Milin Shah
openalex +1 more source
Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet +4 more
wiley +1 more source
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source

